Prognostic factors in patients of advanced non-small cell lung cancer treated with third-line and multi-line therapy with anlotinib
Yang Lifei
Li Yinglong
Tao Jie
Zhang Yuan
Machine-generated Keywords：
Publication Date：2021-10-08
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：4( 1451-1454 )